One or two psilocybin doses still reduce depression symptoms weeks later, with antidepressant effects linked to the intensity of the psychedelic experience

Psilocybin-assisted treatment still appears to reduce depression symptoms for weeks after one or two dosing sessions, with stronger antidepressant effects associated with more intense psychedelic experiences. The central finding links clinical improvement not just to drug exposure, but to the subjective depth of the session. The reported results suggest that even limited dosing can produce measurable benefits in people with depression, adding to evidence that psilocybin may work differently from standard daily antidepressants. Symptom relief persists beyond the acute drug effects, which supports interest in intermittent psychedelic therapy rather than continuous medication. The broader implication is that treatment setting, preparation, and the quality of the experience may be clinically important variables, because the therapeutic outcome seems tied to how powerfully the session is felt as well as to the pharmacology of psilocybin itself.